In our investigation, we have identified significant transcriptomic alterations, particularly in the genes CD3, CD14, CD16, FOSB, S100A12, and TCRɣδ, that differentiate sepsis, mild COVID-19, septic shock, and severe COVID-19. This evidence concerns the gene CD14 and COVID-19.